Thomas, E.; Thankan, R.S.; Purushottamachar, P.; Huang, W.; Kane, M.A.; Zhang, Y.; Ambulos, N.P.; Weber, D.J.; Njar, V.C.O.
Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models. Cells 2022, 11, 2699.
https://doi.org/10.3390/cells11172699
AMA Style
Thomas E, Thankan RS, Purushottamachar P, Huang W, Kane MA, Zhang Y, Ambulos NP, Weber DJ, Njar VCO.
Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models. Cells. 2022; 11(17):2699.
https://doi.org/10.3390/cells11172699
Chicago/Turabian Style
Thomas, Elizabeth, Retheesh S. Thankan, Puranik Purushottamachar, Weiliang Huang, Maureen A. Kane, Yuji Zhang, Nicholas P. Ambulos, David J. Weber, and Vincent C. O. Njar.
2022. "Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models" Cells 11, no. 17: 2699.
https://doi.org/10.3390/cells11172699
APA Style
Thomas, E., Thankan, R. S., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Weber, D. J., & Njar, V. C. O.
(2022). Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant Prostate Cancer In Vitro and In Vivo Models. Cells, 11(17), 2699.
https://doi.org/10.3390/cells11172699
